Complimentary Webinar: Optimizing the Use of Clinical Trial Disclosure Systems

Posted on 11/2/2017

MMS is collaborating with the DIA for an upcoming complimentary webinar, “Optimizing the Use of Clinical Trial Disclosure Systems to Meet Complex and Evolving Global Regulatory Requirements.”

Learning Objectives

  • Determine key drivers for the use of technology to manage clinical trial disclosures processes
  • Implement efficiencies and consistencies gained from enabling reuse of protocol and results summary content across regions
  • Understand the importance of integrating drug and submission-level metrics into disclosures systems
  • Identify system features and functionality that are key to achieving global compliance
  • Recognize the importance of automated workflow management to manage the disclosures life cycle

Presenters

  • Kasim McLain, Manager, Disclosure Services, MMS
  • Peggy Zorn, MS, MBA, Associate Director, Regulatory Affairs, Submissions and Transparency, MMS
  • Gitta Irmer, MS, Associate Director, Data Quality and Standards, Eisai
  • Zach Weingarden, MS, Product Solutions Manager, TrialAssure

View the webinar by clicking here

< Back to News and Media

 

Read On

MMS WINS AWARD FOR MOST INNOVATIVE CLINICAL RESEARCH ORGANIZATION - MMS Holdings

Expedited Drug Development and Review Pathways - MMS Holdings Holdings

by Amanda Beaster, Ph.D. and Janiel Shields

Webinar: RWD & Using RWE in Drug Development - MMS Holdings Holdings